Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Spine fusion by gene therapy.

S T Yoon1, S D Boden

  • 1Department of Orthopaedic Surgery, The Emory Spine Center, Atlanta, GA 30033, USA.

Gene Therapy
|January 16, 2004
PubMed
Summary

Gene therapy offers a promising alternative to bone graft substitutes for enhancing spine fusion success rates. This review highlights key considerations for developing effective gene therapy strategies for bone formation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AOA Critical Issues Symposium: So, You Want to Be a Department Leader: Essentials for Success.

The Journal of bone and joint surgery. American volume·2024
Same author

Improving the clinical evidence of bone graft substitute technology in lumbar spine surgery.

Global spine journal·2013
Same author

Do the adjacent level intervertebral discs degenerate after a lumbar spinal fusion? An experimental study using a rabbit model.

Spine·2010
Same author

The AdLMP-1 transfection in two different cells; AF cells, chondrocytes as potential cell therapy candidates for disc degeneration.

Acta neurochirurgica·2008
Same author

Demineralized bone matrix, bone morphogenetic proteins, and animal models of spine fusion: an overview.

European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·2001
Same author

Do the intervertebral disc cells respond to different levels of hydrostatic pressure?

Clinical biomechanics (Bristol, Avon)·2001

Area of Science:

  • Orthopedics
  • Regenerative Medicine
  • Biotechnology

Background:

  • Spine fusion procedures are common, yet up to 35% fail to achieve solid bony arthrodesis, presenting a significant clinical challenge.
  • Current augmentation methods using osteoinductive proteins have limitations, including cost and carrier material issues.
  • Gene therapy is emerging as a potential alternative strategy to improve bone formation and fusion rates.

Purpose of the Study:

  • To review the current state of local gene therapy for bone formation.
  • To identify critical factors for developing successful gene therapy programs for spine fusion.
  • To highlight challenges and considerations for clinical translation.

Main Methods:

  • Review of existing literature on gene therapy for bone regeneration.
  • Analysis of critical parameters for gene therapy development: gene selection, delivery vectors, dosage, and carrier materials.
  • Discussion of in vitro and in vivo testing strategies.

Main Results:

  • Recombinant human bone morphogenetic protein-2 is FDA-approved for lumbar interbody fusion, but limitations persist.
  • Gene therapy requires careful selection of osteoinductive genes and appropriate delivery vectors.
  • Optimization of effective dose, transduction time, gene transfer method, and carrier scaffolds is crucial.
  • Robust in vitro and in vivo testing strategies are necessary for successful human trials.

Conclusions:

  • Local gene therapy presents a viable alternative to current bone graft augmentation for spine fusion.
  • Successful gene therapy development hinges on strategic choices regarding gene, vector, dose, and delivery system.
  • Further research and rigorous testing are essential to advance gene therapy for bone healing applications.

Related Experiment Videos